Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan for Functional Dyspepsia (PCAB Mechanism Study)
ChiCTR2300070015Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in functional dyspepsia (FD) comparing Tegoprazan with Placebo (2 arms). Primary endpoint: 7-point global overall symptom scale. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
tegoprazan
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2300070015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070015.